Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,906 | 13,637 | 16,215 | 19,660 | 23,645 |
| Other current assets | 759 | 728 | 1,482 | 1,566 | 1,123 |
| TOTAL | $10,665 | $14,365 | $17,696 | $21,225 | $24,767 |
| Non-Current Assets | |||||
| PPE Net | 1,098 | 1,153 | 1,235 | 1,290 | 1,295 |
| Other Non-Current Assets | 39 | 49 | 162 | 167 | 178 |
| TOTAL | $1,137 | $1,201 | $1,397 | $1,456 | $1,473 |
| Total Assets | $11,802 | $15,567 | $19,093 | $22,681 | $26,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 703 | 372 | 836 | 715 | 696 |
| Accrued Expenses | 1,050 | 1,855 | 1,627 | 1,229 | 1,233 |
| TOTAL | $3,132 | $3,457 | $3,694 | $3,339 | $3,325 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,231 | 1,231 | 1,231 | 1,395 | 1,395 |
| TOTAL | $1,231 | $1,538 | $1,846 | $1,989 | $2,338 |
| Total Liabilities | $4,363 | $4,996 | $5,540 | $5,329 | $5,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 341 | 340 | 335 | 334 | 333 |
| Common Shares | 35 | 282 | 277 | 277 | 276 |
| Retained earnings | -141,320 | -137,965 | -134,087 | -129,924 | -126,268 |
| TOTAL | $7,439 | $10,571 | $13,553 | $17,353 | $20,577 |
| Total Liabilities And Equity | $11,802 | $15,567 | $19,093 | $22,681 | $26,240 |